Antimicrobial Agents Practice Questions

Q: Which is the fastest microbicidal agent against M. leprae?

Rifampicin. ***Rifampicin*** - **Rifampicin** is widely recognized as the most rapidly acting bactericidal drug against **Mycobacterium leprae**, leading to rapid clearance of bacilli. - Its potent and fast action is crucial for reducing the bacterial burden quickly and preventing further transmission of **leprosy**. *Minocycline* - **Minocycline** is an effective anti-leprosy drug, but it is **bacteriostatic** rather than rapidly bactericidal compared to rifampicin. - It is often used as an alternative in cases of **drug resistance** or intolerance to first-line agents but is not the fastest acting. *Clofazimine* - **Clofazimine** is an anti-leprosy drug with **bacteriostatic** and anti-inflammatory properties, but its action is slower than rifampicin. - It is valuable in multi-drug therapy for preventing resistance and managing **lepromatous leprosy**, but not for rapid killing. *Dapsone* - **Dapsone** is a foundational anti-leprosy drug, but its action against **M. leprae** is generally considered **bacteriostatic** and slow. - While essential for long-term treatment, it does not achieve the rapid sterilizing effect seen with rifampicin.

Q: Which of the following antifungal agents is primarily used topically?

Nystatin. ***Nystatin*** - **Nystatin** is commonly used as a **topical** or **oral swish-and-swallow** antifungal agent for candidal infections of the skin, mucous membranes, and gastrointestinal tract. - It works by binding to **ergosterol** in fungal cell membranes, leading to pore formation and cell death. *Itraconazole* - **Itraconazole** is an **oral** or **intravenous** antifungal agent primarily used for systemic fungal infections or onychomycosis, not typically for topical application. - It works by inhibiting **cytochrome P450-dependent enzymes**, which are essential for ergosterol synthesis. *Griseofulvin* - **Griseofulvin** is an **oral** antifungal used to treat dermatophyte infections of the skin, hair, and nails, especially when topical treatments are ineffective. - It binds to **keratin** in newly formed tissue, making it resistant to fungal invasion. *Voriconazole* - **Voriconazole** is a broad-spectrum **systemic (oral or IV)** antifungal agent, particularly useful for invasive aspergillosis and other serious fungal infections. - It is a **triazole antifungal** that inhibits fungal cytochrome P450 enzymes involved in ergosterol synthesis.

Q: Thalidomide is useful in:

Treatment of type II lepra reaction. ***Treatment of type II lepra reaction*** - **Thalidomide** is highly effective in managing the severe inflammatory response seen in **Type II lepra reaction** (erythema nodosum leprosum, ENL). - Its efficacy in ENL is primarily due to its **anti-inflammatory** and **immunomodulatory** properties, inhibiting TNF-α. *Treatment of leprosy* - **Thalidomide** is not a primary antibacterial drug and thus does not directly treat the underlying **Mycobacterium leprae infection**. - Its role is limited to modulating the immune response during a reaction, not eradicating the bacteria. *Treatment of type I lepra reaction* - **Type I lepra reaction** (reversal reaction) is typically managed with **corticosteroids**, not thalidomide. - Type I reactions involve a delayed-type hypersensitivity response, distinct from the immune complex-mediated Type II reaction. *Treatment of neuritic leprosy* - **Neuritic leprosy** refers to nerve damage caused by the infection itself, or during both types of reactions, and its treatment focuses on preventing further damage with **multidrug therapy** and corticosteroids. - While thalidomide can reduce inflammation in Type II reactions that might contribute to nerve damage, it's not a direct treatment for the established nerve damage itself.

Q: Which of the following is effective against Pseudomonas and is used in burns patients?

Silver sulfadiazine. ***Silver sulfadiazine*** - This antimicrobial agent is widely recognized for its effectiveness against a broad spectrum of bacteria, including **Pseudomonas aeruginosa**, a common pathogen in **burn wounds**. - Its mechanism involves the gradual release of **silver ions** and **sulfadiazine**, which together inhibit bacterial growth and prevent infection in burn patients. *Sulphadoxine* - Sulphadoxine is a **long-acting sulfonamide antibiotic** primarily used in combination with pyrimethamine for the treatment of **malaria**. - It does not have a primary role in the topical management of **burn wounds** or specific efficacy against **Pseudomonas**. *Sulphamethoxazole* - Sulphamethoxazole is a **medium-acting sulfonamide** commonly combined with trimethoprim (**co-trimoxazole**) to treat various bacterial infections, including **urinary tract infections** and respiratory infections. - While it has antibacterial properties, it is not typically used topically for **burns** and is not specifically favored for **Pseudomonas** coverage in this context. *Silver sulphazine* - This is a **non-existent medication** - a deliberate distractor with incorrect spelling. - The correct medication is **silver sulfadiazine** (not "sulphazine"), making this a common exam trap to test precise knowledge of antimicrobial nomenclature.

Q: A diabetic patient developed cellulitis due to S. aureus, which was found to be methicillin resistant on the antibiotic sensitivity testing. All of the following antibiotics will be appropriate except ?

Imipenem. ***Imipenem*** - **Imipenem** is a carbapenem antibiotic that is effective against many Gram-positive and Gram-negative bacteria, but it is **not active against MRSA (methicillin-resistant *Staphylococcus aureus*)**. - MRSA strains are resistant to all beta-lactam antibiotics, including penicillins, cephalosporins, and carbapenems like imipenem, due to the presence of the **mecA gene** which encodes for an altered penicillin-binding protein (PBP2a). *Vancomycin* - **Vancomycin** is a glycopeptide antibiotic that is a primary choice for treating **MRSA infections**, including cellulitis. - It inhibits cell wall synthesis by binding to the D-Ala-D-Ala precursor, preventing cross-linking, and is specifically active against **Gram-positive bacteria**. *Teicoplanin* - **Teicoplanin** is another glycopeptide antibiotic, similar to vancomycin, and is also considered a suitable agent for treating **MRSA infections**. - It works by inhibiting bacterial cell wall synthesis and has a **longer half-life** than vancomycin, allowing for less frequent dosing. *Linezolid* - **Linezolid** is an oxazolidinone antibiotic known for its activity against **Gram-positive bacteria**, including **MRSA** and vancomycin-resistant enterococci (VRE). - It inhibits protein synthesis by binding to the 50S ribosomal subunit, preventing the formation of the initiation complex.

Q: Ivermectin is indicated in the treatment of:

Scabies. ***Scabies*** - **Ivermectin** is an effective oral antiparasitic agent used to treat **scabies**, particularly in cases of widespread infestation, crusted scabies, or when topical treatments fail. - It acts by paralyzing and killing the **Sarcoptes scabiei mites** responsible for the infestation. *Dermatophytosis* - **Dermatophytosis** (ringworm) is a **fungal infection** of the skin, hair, or nails. - It is typically treated with **antifungal medications** (e.g., azoles, terbinafine), not ivermectin. *Tuberculosis* - **Tuberculosis** is a bacterial infection caused by **Mycobacterium tuberculosis**, primarily affecting the lungs. - Treatment involves a multi-drug regimen of **antibiotics** (e.g., rifampin, isoniazid), for several months. *Syphilis* - **Syphilis** is a sexually transmitted bacterial infection caused by **Treponema pallidum**. - The primary treatment for syphilis is **penicillin**, usually administered via injection.

Q: Contact lens staining occurs in which ATT drug?

Rifampicin. ***Rifampicin*** - **Rifampicin** causes **red-orange discoloration** of bodily fluids, including tears. - This discoloration can **permanently stain soft contact lenses**, making this an important patient counseling point. *INH (Isoniazid)* - **INH** is primarily associated with **hepatotoxicity** and **peripheral neuropathy** due to pyridoxine deficiency. - It does not cause significant discoloration of bodily fluids or contact lens staining. *Pyrazinamide* - **Pyrazinamide** is known for causing **hyperuricemia** and **hepatotoxicity**. - It does not lead to discoloration of bodily fluids or contact lenses. *Thioacetazone* - **Thioacetazone** (not a first-line ATT drug) is associated with severe **cutaneous hypersensitivity reactions**, including Stevens-Johnson syndrome. - It does not cause the characteristic discoloration or contact lens staining seen with rifampicin.

Q: Minimum TB resistance is seen with which drug?

Ethambutol. ***Ethambutol*** - Among the first-line anti-TB drugs, **Ethambutol** has the **lowest rates of resistance development** - Resistance to Ethambutol is **less common** than to other first-line drugs like Isoniazid or Rifampicin - This makes it a valuable component of TB treatment regimens, particularly in maintaining effectiveness of combination therapy - Ethambutol resistance does occur but is relatively uncommon compared to other first-line agents *Isoniazid* - **Isoniazid resistance** is very common, occurring in approximately 10-15% of TB cases globally - Resistance arises from mutations in genes like *katG* and *inhA*, affecting drug activation and target binding - Despite resistance concerns, it remains a cornerstone drug due to its high efficacy when susceptibility is present *Rifampicin* - **Rifampicin resistance** is less common than Isoniazid but still significant - **Rifampicin-resistant TB (RR-TB)** is a marker for multidrug-resistant TB (MDR-TB) and indicates more severe disease - Development of Rifampicin resistance necessitates longer treatment regimens with second-line drugs *Streptomycin* - Historically one of the first antibiotics used for TB, but **resistance developed relatively quickly and is now widespread** - Due to the **high prevalence of resistance**, Streptomycin is no longer considered a first-line drug in most treatment programs - Has the highest resistance rates among the options listed

Q: Not True about Bedaquiline

Contraindicated in pregnancy. ***Contraindicated in pregnancy*** - While bedaquiline's safety in pregnancy is not fully established, it is generally **not absolutely contraindicated** if the potential benefits outweigh the risks, especially in cases of MDR-TB. - Current guidelines suggest that it can be used with caution, and a woman taking bedaquiline should use **effective contraception** throughout treatment. *Inhibits mycobacterial ATP synthase* - This statement is **true**. Bedaquiline specifically targets the **F0F1-ATP synthase enzyme** in *Mycobacterium tuberculosis*. - By inhibiting this enzyme, bedaquiline disrupts the **energy production** pathway of the bacteria, leading to bacterial death. *Given in > 10 years aged patients* - This statement is **true**. Bedaquiline is approved for use in patients with **multidrug-resistant tuberculosis (MDR-TB)** who are **12 years of age and older**. - Its use in younger children is still under investigation, though some compassionate use cases exist. *Given for MDR-TB patients* - This statement is **true**. Bedaquiline is a key drug in the treatment of **multidrug-resistant tuberculosis (MDR-TB)** and **extensively drug-resistant tuberculosis (XDR-TB)**. - It is often used as part of a **combination regimen** to overcome drug resistance to first-line agents.

Q: Persistent suppression of microbial growth below MIC is known as:

Post antibiotic effect. ***Post antibiotic effect*** - This phenomenon refers to the continued **suppression of bacterial growth** even after the antibiotic concentration has fallen below the **minimum inhibitory concentration (MIC)**. - It allows for less frequent dosing intervals without compromising efficacy. - Clinically important for **aminoglycosides and fluoroquinolones**, which exhibit significant PAE. *Paradoxical effect* - The **paradoxical effect** (or Eagle effect) refers to the phenomenon where certain antibiotics, particularly penicillin, become *less effective* at very high concentrations. - This effect is not about persistent suppression below MIC, but rather a **decreased bactericidal activity** at concentrations far exceeding MIC. *Post exposure prophylaxis* - **Post exposure prophylaxis (PEP)** refers to preventive treatment given after exposure to an infectious agent (e.g., HIV PEP, rabies PEP). - This is a clinical intervention strategy, not a pharmacodynamic phenomenon describing antibiotic behavior below MIC. *Adverse effect* - An **adverse effect** refers to an unintended and undesirable reaction to a drug, which is not relevant to the described microbial growth suppression. - This term describes harmful side effects experienced by the patient, not a microbiological phenomenon.

Question 1

Which is the fastest microbicidal agent against M. leprae?

Accepted Answer

Rifampicin

Answer

Minocycline

Answer

Clofazimine

Answer

Dapsone

Question 2

Which of the following antifungal agents is primarily used topically?

Accepted Answer

Nystatin

Answer

Itraconazole

Answer

Griseofulvin

Answer

Voriconazole

Question 3

Thalidomide is useful in:

Accepted Answer

Treatment of type II lepra reaction

Answer

Treatment of leprosy

Answer

Treatment of type I lepra reaction

Answer

Treatment of neuritic leprosy

Question 4

Which of the following is effective against Pseudomonas and is used in burns patients?

Accepted Answer

Silver sulfadiazine

Answer

Sulphadoxine

Answer

Sulphamethoxazole

Answer

Silver sulphazine

Question 5

A diabetic patient developed cellulitis due to S. aureus, which was found to be methicillin resistant on the antibiotic sensitivity testing. All of the following antibiotics will be appropriate except ?

Accepted Answer

Imipenem

Answer

Vancomycin

Answer

Teicoplanin

Answer

Linezolid

Question 6

Ivermectin is indicated in the treatment of:

Accepted Answer

Scabies

Answer

Dermatophytosis

Answer

Tuberculosis

Answer

Syphilis

Question 7

Contact lens staining occurs in which ATT drug?

Accepted Answer

Rifampicin

Answer

INH

Answer

Thioacetazone

Answer

Pyrazinamide

Question 8

Minimum TB resistance is seen with which drug?

Accepted Answer

Ethambutol

Answer

Rifampicin

Answer

Streptomycin

Answer

Isoniazid

Question 9

Not True about Bedaquiline

Accepted Answer

Contraindicated in pregnancy

Answer

Inhibits mycobacterial ATP synthase

Answer

Given in > 10 years aged patients

Answer

Given for MDR-TB patients

Question 10

Persistent suppression of microbial growth below MIC is known as:

Accepted Answer

Post antibiotic effect

Answer

Paradoxical effect

Answer

Adverse effect

Answer

Post exposure prophylaxis

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?